{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:36:36Z","timestamp":1785803796390,"version":"3.56.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31AG077931"],"award-info":[{"award-number":["F31AG077931"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR065971"],"award-info":[{"award-number":["AR065971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hampton Roads Biomedical Research Consortium Collaboration Accelerator Fund"},{"name":"Richard L Roudebush VA Medical Center","award":["BX006399"],"award-info":[{"award-number":["BX006399"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>SARS-CoV-2 drove the catastrophic global phenomenon of the COVID-19 pandemic resulting in a multitude of systemic health issues, including bone loss. The purpose of this review is to summarize recent findings related to bone loss and potential mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>The early clinical evidence indicates an increase in vertebral fractures, hypocalcemia, vitamin D deficiencies, and a loss in BMD among COVID-19 patients. Additionally, lower BMD is associated with more severe SARS-CoV-2 infection. Preclinical models have shown bone loss and increased osteoclastogenesis. The bone loss associated with SARS-CoV-2 infection could be the result of many factors that directly affect the bone such as higher inflammation, activation of the NLRP3 inflammasome, recruitment of Th17 cells, the hypoxic environment, and changes in RANKL\/OPG signaling. Additionally, SARS-CoV-2 infection can exert indirect effects on the skeleton, as mechanical unloading may occur with severe disease (e.g., bed rest) or with BMI loss and muscle wasting that has also been shown to occur with SARS-CoV-2 infection. Muscle wasting can also cause systemic issues that may influence the bone. Medications used to treat SARS-CoV-2 infection also have a negative effect on the bone. Lastly, SARS-CoV-2 infection may also worsen conditions such as diabetes and negatively affect kidney function, all of which could contribute to bone loss and increased fracture risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>SARS-CoV-2 can negatively affect the bone through multiple direct and indirect mechanisms. Future work will be needed to determine what patient populations are at risk of COVID-19-related increases in fracture risk, the mechanisms behind bone loss, and therapeutic options.\u00a0This review article is part of a series of multiple manuscripts designed to determine the utility of using artificial intelligence for writing scientific reviews.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11914-023-00842-2","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T04:10:52Z","timestamp":1705291852000},"page":"122-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["COVID-19 and Bone Loss: A Review of Risk Factors, Mechanisms, and Future Directions"],"prefix":"10.1007","volume":"22","author":[{"given":"Amy","family":"Creecy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatundun D.","family":"Awosanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Ozanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Toepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Kacena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McCune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"842_CR1","doi-asserted-by":"publisher","unstructured":"Kacena MA, Plotkin LI, Fehrenbacher JC. The use of artificial intelligence in writing scientific review articles. Curr Osteoporos Rep. https:\/\/doi.org\/10.1007\/s11914-023-00852-0.","DOI":"10.1007\/s11914-023-00852-0"},{"key":"842_CR2","doi-asserted-by":"publisher","unstructured":"Awosanya OD, Harris A, Creecy A, et al. The utility of AI in writing a scientific review article on the impacts of\u00a0COVID-19\u00a0on musculoskeletal health. Curr Osteoporos Rep. 2024. https:\/\/doi.org\/10.1007\/s11914-023-00855-x.","DOI":"10.1007\/s11914-023-00855-x"},{"key":"842_CR3","unstructured":"WHO Coronavirus (COVID-19) Dashboard. 2023, World Health Organization."},{"key":"842_CR4","doi-asserted-by":"crossref","unstructured":"Chams N, et al. COVID-19: a multidisciplinary review. Frontiers in Public Health, 2020. 8.","DOI":"10.3389\/fpubh.2020.00383"},{"issue":"18","key":"842_CR5","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W-J Guan","year":"2020","unstructured":"Guan W-J, et al. Clinical characteristics of coronavirus disease 2019 in China. New England J Med. 2020;382(18):1708\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","journal-title":"New England J Med."},{"issue":"20","key":"842_CR6","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052\u20139.","journal-title":"JAMA"},{"issue":"21","key":"842_CR7","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","volume":"382","author":"PK Bhatraju","year":"2020","unstructured":"Bhatraju PK, et al. Covid-19 in critically ill patients in the Seattle region \u2014 case series. New England J Med. 2020;382(21):2012\u201322.","journal-title":"New England J Med."},{"issue":"6","key":"842_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ajcp\/aqaa062","volume":"153","author":"LM Barton","year":"2020","unstructured":"Barton LM, et al. COVID-19 autopsies, Oklahoma, USA. Ame J Clin Pathol. 2020;153(6):725\u201333.","journal-title":"Ame J Clin Pathol."},{"key":"842_CR9","doi-asserted-by":"publisher","first-page":"100330","DOI":"10.1016\/j.lanepe.2022.100330","volume":"15","author":"S von Stillfried","year":"2022","unstructured":"von Stillfried S, et al. First report from the German COVID-19 autopsy registry. The Lancet Regional Health - Europe. 2022;15:100330.","journal-title":"The Lancet Regional Health - Europe"},{"issue":"14","key":"842_CR10","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2106\/JBJS.20.00847","volume":"102","author":"NP Disser","year":"2020","unstructured":"Disser NP, et al. Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. 2020;102(14):1197\u2013204.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"842_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-med-042420-104753","volume":"74","author":"M Brogan","year":"2023","unstructured":"Brogan M, Ross MJ. COVID-19 and kidney disease. Annual Rev Med. 2023;74(1):1\u201313.","journal-title":"Annual Rev Med."},{"key":"842_CR12","doi-asserted-by":"publisher","unstructured":"Gambella A, et al. Spectrum of kidney injury following COVID-19 disease: renal biopsy findings in a single italian pathology service. Biomolecules, 2022;12. https:\/\/doi.org\/10.3390\/biom12020298.","DOI":"10.3390\/biom12020298"},{"issue":"1","key":"842_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/aje\/kwaa191","volume":"190","author":"SA G\u00f3mez-Ochoa","year":"2021","unstructured":"G\u00f3mez-Ochoa SA, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021;190(1):161\u201375.","journal-title":"Am J Epidemiol."},{"issue":"3","key":"842_CR14","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/jmv.26424","volume":"93","author":"J Li","year":"2021","unstructured":"Li J, et al. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93(3):1449\u201358.","journal-title":"J Med Virol."},{"key":"842_CR15","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446. https:\/\/doi.org\/10.3389\/fimmu.2020.01446.","journal-title":"Front Immunol"},{"key":"842_CR16","doi-asserted-by":"publisher","first-page":"107225","DOI":"10.1016\/j.intimp.2020.107225","volume":"90","author":"R Pasrija","year":"2021","unstructured":"Pasrija R, Naime M. The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease. Int Immunopharmacol. 2021;90:107225.","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"842_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/infdis\/jiab167","volume":"224","author":"F Syed","year":"2021","unstructured":"Syed F, et al. Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19. J Infectious Dis. 2021;224(1):60\u20139.","journal-title":"J Infectious Dis."},{"issue":"1","key":"842_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13073-021-00881-3","volume":"13","author":"F Zhang","year":"2021","unstructured":"Zhang F, et al. IFN-\u03b3 and TNF-\u03b1 drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. Genome Med. 2021;13(1):64.","journal-title":"Genome Med."},{"issue":"4","key":"842_CR19","first-page":"282","volume":"13","author":"N Amiri-Dashatan","year":"2020","unstructured":"Amiri-Dashatan N, et al. Increased inflammatory markers correlate with liver damage and predict severe COVID-19: a systematic review and meta-analysis. Gastroenterol Hepatol Bed Bench. 2020;13(4):282\u201391.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"8","key":"842_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(23)00239-4","volume":"11","author":"M Parotto","year":"2023","unstructured":"Parotto M, et al. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respiratory Med. 2023;11(8):739\u201354.","journal-title":"Lancet Respiratory Med."},{"issue":"4","key":"842_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11914-022-00734-x","volume":"20","author":"OD Awosanya","year":"2022","unstructured":"Awosanya OD, et al. The Impacts of COVID-19 on Musculoskeletal Health. Current Osteoporosis Rep. 2022;20(4):213\u201325.","journal-title":"Current Osteoporosis Rep."},{"issue":"9","key":"842_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00011-022-01616-9","volume":"71","author":"L Sapra","year":"2022","unstructured":"Sapra L, et al. Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics. Inflammation Res. 2022;71(9):1025\u201340.","journal-title":"Inflammation Res."},{"issue":"1","key":"842_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-020-02541-9","volume":"71","author":"L di Filippo","year":"2021","unstructured":"di Filippo L, et al. Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients. Endocrine. 2021;71(1):9\u201313.","journal-title":"Endocrine"},{"issue":"3","key":"842_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12020-020-02383-5","volume":"68","author":"L Di Filippo","year":"2020","unstructured":"Di Filippo L, et al. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine. 2020;68(3):475\u20138.","journal-title":"Endocrine"},{"key":"842_CR25","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kerschan-Schindl, K., et al., Moderate COVID-19 disease is associated with reduced bone turnover. Journal of Bone and Mineral Research, 2023. An interesting study determining alterations in serum bone turnover markers were present in hospitalized COVID-19 patients that did not require mechanical ventilation, indicating that even moderate disease could affect fracture risk.","DOI":"10.1002\/jbmr.4822"},{"issue":"2","key":"842_CR26","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1210\/clinem\/dgaa738","volume":"106","author":"L di Filippo","year":"2021","unstructured":"\u2022\u2022 di Filippo L, et al. Radiological thoracic vertebral fractures are highly prevalent in COVID-19 and predict disease outcomes. The Journal of Clinical Endocrinology & Metabolism. 2021;106(2):e602\u201314. This study determined that vertebral fractures can be used to predict disease outcomes, either as a measure of marker of frailty or as a measure of severe disease, and indicates potential skeletal effects of SARS-CoV-2 infection.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"842_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12020-021-02872-1","volume":"74","author":"S Battisti","year":"2021","unstructured":"Battisti S, et al. Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency. Endocrine. 2021;74(3):461\u20139.","journal-title":"Endocrine"},{"issue":"2","key":"842_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12020-022-03096-7","volume":"77","author":"L di Filippo","year":"2022","unstructured":"di Filippo L, et al. Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors. Endocrine. 2022;77(2):392\u2013400.","journal-title":"Endocrine"},{"key":"842_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115790","volume":"144","author":"J Kottlors","year":"2021","unstructured":"Kottlors J, et al. Early extrapulmonary prognostic features in chest computed tomography in COVID-19 pneumonia: Bone mineral density is a relevant predictor for the clinical outcome - a multicenter feasibility study. Bone. 2021;144: 115790.","journal-title":"Bone"},{"issue":"4","key":"842_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jocd.2021.07.007","volume":"24","author":"M Tahtabasi","year":"2021","unstructured":"Tahtabasi M, et al. The prognostic value of vertebral bone density on chest CT in hospitalized COVID-19 patients. J Clin Densitom. 2021;24(4):506\u201315.","journal-title":"J Clin Densitom"},{"issue":"8","key":"842_CR31","first-page":"3046","volume":"26","author":"B Berkta\u015f","year":"2022","unstructured":"Berkta\u015f B, et al. COVID-19 illness and treatment decrease bone mineral density of surviving hospitalized patients. Eur Rev Med Pharmacol Sci. 2022;26(8):3046\u201356.","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"1","key":"842_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s43166-022-00165-7","volume":"49","author":"SH Elmedany","year":"2022","unstructured":"Elmedany SH, et al. Bone mineral density changes in osteoporotic and osteopenic patients after COVID-19 infection. Egyptian Rheumatol Rehab. 2022;49(1):64.","journal-title":"Egyptian Rheumatol Rehab."},{"key":"842_CR33","doi-asserted-by":"crossref","unstructured":"Al-Azzawi IS, Mohammed NS, Saad I, The impact of angiotensin converting enzyme-2 (ACE-2) on bone remodeling marker osteoprotegerin (OPG) in post-COVID-19 Iraqi patients. Cureus, 2022;14(10).","DOI":"10.7759\/cureus.29926"},{"key":"842_CR34","doi-asserted-by":"publisher","first-page":"112087","DOI":"10.1016\/j.matdes.2023.112087","volume":"231","author":"F Buccino","year":"2023","unstructured":"\u2022 Buccino F, et al. Osteoporosis and Covid-19: detected similarities in bone lacunar-level alterations via combined AI and advanced synchrotron testing. Materials & Design. 2023;231:112087. An interesting study determining alterations in serum bone turnover markers were present in hospitalized COVID-19 patients that did not require mechanical ventilation, indicating that even moderate disease could affect fracture risk.","journal-title":"Materials & Design"},{"issue":"9","key":"842_CR35","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00705-009-0472-z","volume":"154","author":"S Obitsu","year":"2009","unstructured":"Obitsu S, et al. Potential enhancement of osteoclastogenesis by severe acute respiratory syndrome coronavirus 3a\/X1 protein. Archives Virolog. 2009;154(9):1457\u201364.","journal-title":"Archives Virolog."},{"key":"842_CR36","doi-asserted-by":"publisher","first-page":"115041","DOI":"10.1016\/j.bone.2019.115041","volume":"128","author":"CM Queiroz-Junior","year":"2019","unstructured":"Queiroz-Junior CM, et al. The angiotensin converting enzyme 2\/angiotensin-(1\u20137)\/Mas receptor axis as a key player in alveolar bone remodeling. Bone. 2019;128:115041.","journal-title":"Bone"},{"key":"842_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bbrc.2021.01.104","volume":"546","author":"C Duarte","year":"2021","unstructured":"Duarte C, et al. Age-dependent effects of the recombinant spike protein\/SARS-CoV-2 on the M-CSF\u2013 and IL-34-differentiated macrophages in vitro. Biochem Biophys Res Commun. 2021;546:97\u2013102.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"842_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11684-021-0906-x","volume":"16","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang H, Zhang W. SARS-CoV-2 variants, immune escape, and countermeasures. Front Med. 2022;16(2):196\u2013207.","journal-title":"Front Med."},{"issue":"7830","key":"842_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","volume":"586","author":"C Mu\u00f1oz-Fontela","year":"2020","unstructured":"Mu\u00f1oz-Fontela C, et al. Animal models for COVID-19. Nature. 2020;586(7830):509\u201315.","journal-title":"Nature"},{"key":"842_CR40","doi-asserted-by":"crossref","unstructured":"Hassler L, et al. A novel soluble ACE2 protein provides lung and kidney protection in mice susceptible to lethal SARS-CoV-2 infection. Journal of the American Society of Nephrology, 2022;33(7).","DOI":"10.1681\/ASN.2021091209"},{"issue":"11","key":"842_CR41","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","volume":"21","author":"ES Winkler","year":"2020","unstructured":"Winkler ES, et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nature Immunol. 2020;21(11):1327\u201335.","journal-title":"Nature Immunol."},{"issue":"3","key":"842_CR42","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cell.2020.06.010","volume":"182","author":"J Sun","year":"2020","unstructured":"Sun J, et al. Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment. Cell. 2020;182(3):734-743.e5.","journal-title":"Cell"},{"issue":"9","key":"842_CR43","first-page":"2428","volume":"71","author":"JF-W Chan","year":"2020","unstructured":"Chan JF-W, et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis. 2020;71(9):2428\u201346.","journal-title":"Clin Infect Dis."},{"issue":"1","key":"842_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"S Piplani","year":"2021","unstructured":"Piplani S, et al. In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin. Scientific Rep. 2021;11(1):1\u201313.","journal-title":"Scientific Rep."},{"key":"842_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116227","volume":"154","author":"OD Awosanya","year":"2022","unstructured":"\u2022\u2022 Awosanya OD, et al. Osteoclast-mediated bone loss observed in a COVID-19 mouse model. Bone. 2022;154: 116227.  This study was the first to show bone loss with SARS-CoV-2 in a preclinical model.","journal-title":"Bone"},{"issue":"9","key":"842_CR46","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/jor.25537","volume":"41","author":"AK Haudenschild","year":"2023","unstructured":"\u2022 Haudenschild AK, et al. Acute bone loss following SARS-CoV-2 infection in mice. J Orthopaed Res. 2023;41(9):1945\u201352. This study demonstrated bone loss and decreased growth plate in male and female mice with SARS-CoV-2 infection.","journal-title":"J Orthopaed Res."},{"issue":"1","key":"842_CR47","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1038\/s41467-022-30195-w","volume":"13","author":"W Qiao","year":"2022","unstructured":"\u2022\u2022 Qiao W, et al. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat Commun. 2022;13(1):2539.  This study showed a pro-inflammatory response and bone in a preclinical model that indicated the side effects were not due to direct infection.","journal-title":"Nat Commun."},{"issue":"5","key":"842_CR48","doi-asserted-by":"publisher","first-page":"2200007","DOI":"10.1002\/adbi.202200007","volume":"6","author":"J Gao","year":"2022","unstructured":"Gao J, et al. Neuropilin-1-mediated SARS-CoV-2 infection in bone marrow-derived macrophages inhibits osteoclast differentiation. Advanced Biology. 2022;6(5):2200007.","journal-title":"Advanced Biology"},{"issue":"1","key":"842_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","volume":"25","author":"P Dandona","year":"2004","unstructured":"Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25(1):4\u20137.","journal-title":"Trends Immunol."},{"key":"842_CR50","doi-asserted-by":"crossref","unstructured":"Zioupos P, Currey JD, Hammer AJ. The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res. 1999;45. 108-116.","DOI":"10.1002\/(SICI)1097-4636(199905)45:2<108::AID-JBM5>3.3.CO;2-1"},{"issue":"6937","key":"842_CR51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337\u201342.","journal-title":"Nature"},{"key":"842_CR52","doi-asserted-by":"publisher","unstructured":"Murakami T, et al. Activation and function of NLRP3 inflammasome in bone and joint-related diseases. Int J Molecular Sci, 2022;23. https:\/\/doi.org\/10.3390\/ijms23105365.","DOI":"10.3390\/ijms23105365"},{"issue":"2","key":"842_CR53","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cei.13167","volume":"194","author":"C Guo","year":"2018","unstructured":"Guo C, et al. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis. Clin Exp Immunol. 2018;194(2):231\u201343.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"842_CR54","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/thno.47860","volume":"11","author":"X Yang","year":"2021","unstructured":"Yang X, et al. Tofacitinib restores the balance of \u03b3\u03b4Treg\/\u03b3\u03b4T17 cells in rheumatoid arthritis by inhibiting the NLRP3 inflammasome. Theranostics. 2021;11(3):1446\u201357.","journal-title":"Theranostics"},{"issue":"6","key":"842_CR55","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","volume":"73","author":"JM Rebeccah","year":"2014","unstructured":"Rebeccah JM, et al. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals Rheumatic Dis. 2014;73(6):1202.","journal-title":"Annals Rheumatic Dis."},{"issue":"36","key":"842_CR56","doi-asserted-by":"publisher","first-page":"14867","DOI":"10.1073\/pnas.1111101108","volume":"108","author":"C Jin","year":"2011","unstructured":"Jin C, et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc National Academy Sci. 2011;108(36):14867\u201372.","journal-title":"Proc National Academy Sci."},{"issue":"2","key":"842_CR57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/09513590.2021.2015760","volume":"38","author":"L Lu","year":"2022","unstructured":"Lu L, et al. Drynaria fortunei improves lipid profiles of elderly patients with postmenopausal osteoporosis via regulation of Notch1-NLRP3 inflammasome-mediated inflammation. Gynecol Endocrinol. 2022;38(2):176\u201380.","journal-title":"Gynecol Endocrinol."},{"issue":"1","key":"842_CR58","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1038\/s41598-017-07014-0","volume":"7","author":"Y Alippe","year":"2017","unstructured":"Alippe Y, et al. Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation. Sci Rep. 2017;7(1):6630.","journal-title":"Sci Rep."},{"issue":"4","key":"842_CR59","doi-asserted-by":"publisher","first-page":"e35979","DOI":"10.1371\/journal.pone.0035979","volume":"7","author":"SL Bonar","year":"2012","unstructured":"Bonar SL, et al. Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLOS ONE. 2012;7(4):e35979.","journal-title":"PLOS ONE"},{"key":"842_CR60","doi-asserted-by":"publisher","first-page":"33680","DOI":"10.1038\/srep33680","volume":"6","author":"MN Mansoori","year":"2016","unstructured":"Mansoori MN, et al. IL-18BP is decreased in osteoporotic women: prevents inflammasome mediated IL-18 activation and reduces Th17 differentiation. Sci Rep. 2016;6:33680.","journal-title":"Sci Rep"},{"key":"842_CR61","doi-asserted-by":"publisher","first-page":"752546","DOI":"10.3389\/fendo.2021.752546","volume":"12","author":"N Jiang","year":"2021","unstructured":"Jiang N, et al. NLRP3 Inflammasome: a new target for prevention and control of osteoporosis?\u00a0Front Endocrinol. 2021;12:752546. https:\/\/doi.org\/10.3389\/fendo.2021.752546.","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"842_CR62","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12015-020-10010-z","volume":"17","author":"MZ Ratajczak","year":"2021","unstructured":"Ratajczak MZ, et al. SARS-CoV-2 entry receptor ACE2 is expressed on very small CD45\u2212 precursors of hematopoietic and endothelial cells and in response to virus spike protein activates the Nlrp3 inflammasome. Stem Cell Rev Rep. 2021;17(1):266\u201377.","journal-title":"Stem Cell Rev Rep."},{"issue":"3","key":"842_CR63","doi-asserted-by":"publisher","first-page":"e20201707","DOI":"10.1084\/jem.20201707","volume":"218","author":"TS Rodrigues","year":"2020","unstructured":"\u2022 Rodrigues TS, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2020;218(3):e20201707. This study examined serum from patients and used SARS-CoV-2-infected human cell lines to determine the activation of the inflammasome along with other inflammatory markers with SARS-CoV-2 infection.","journal-title":"J Exp Med."},{"key":"842_CR64","doi-asserted-by":"publisher","first-page":"203705","DOI":"10.1155\/2013\/203705","volume":"2013","author":"M Wang","year":"2013","unstructured":"Wang M, et al. Th17 and Treg cells in bone related diseases. Clin Dev Immunol. 2013;2013:203705.","journal-title":"Clin Dev Immunol."},{"issue":"11","key":"842_CR65","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrrheum.2012.167","volume":"8","author":"H Takayanagi","year":"2012","unstructured":"Takayanagi H. New developments in osteoimmunology. Nature Rev Rheuma. 2012;8(11):684\u20139.","journal-title":"Nature Rev Rheuma."},{"issue":"12","key":"842_CR66","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203(12):2673\u201382.","journal-title":"J Exp Med."},{"key":"842_CR67","doi-asserted-by":"crossref","unstructured":"Dar HY, et al. Callus \u03b3\u03b4 T cells and microbe-induced intestinal Th17 cells improve fracture healing in mice. J Clin Invest. 2023;133(8).","DOI":"10.1172\/JCI166577"},{"key":"842_CR68","doi-asserted-by":"publisher","unstructured":"Martonik D, et al. The role of Th17 response in COVID-19. Cells, 2021;10, https:\/\/doi.org\/10.3390\/cells10061550.","DOI":"10.3390\/cells10061550"},{"issue":"15","key":"842_CR69","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan China. Clin Infect Dis. 2020;71(15):762\u20138.","journal-title":"Clin Infect Dis."},{"key":"842_CR70","doi-asserted-by":"publisher","first-page":"155323","DOI":"10.1016\/j.cyto.2020.155323","volume":"137","author":"A Ghazavi","year":"2021","unstructured":"Ghazavi A, et al. Cytokine profile and disease severity in patients with COVID-19. Cytokine. 2021;137:155323.","journal-title":"Cytokine"},{"issue":"2","key":"842_CR71","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jcp.29921","volume":"236","author":"SS Hannah","year":"2021","unstructured":"Hannah SS, et al. \u201cTake My Bone Away?\u201d Hypoxia and bone: a narrative review. J Cell Physio. 2021;236(2):721\u201340.","journal-title":"J Cell Physio."},{"issue":"9","key":"842_CR72","first-page":"Oc32","volume":"10","author":"K Ramachandran","year":"2016","unstructured":"Ramachandran K, et al. Prevalence of bone mineral density abnormalities and factors affecting bone density in patients with chronic obstructive pulmonary disease in a tertiary care hospital in Southern India. J Clin Diagn Res. 2016;10(9):Oc32-oc34.","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"842_CR73","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00774-015-0691-1","volume":"34","author":"R Terzi","year":"2016","unstructured":"Terzi R, Y\u0131lmaz Z. Bone mineral density and changes in bone metabolism in patients with obstructive sleep apnea syndrome. J Bone Mineral Meta. 2016;34(4):475\u201381.","journal-title":"J Bone Mineral Meta."},{"issue":"3","key":"842_CR74","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3109\/15412555.2012.744390","volume":"10","author":"EP Rutten","year":"2013","unstructured":"Rutten EP, et al. Anemia is associated with bone mineral density in chronic obstructive pulmonary disease. Copd. 2013;10(3):286\u201392.","journal-title":"Copd"},{"issue":"10","key":"842_CR75","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.yexcr.2006.02.007","volume":"312","author":"JC Utting","year":"2006","unstructured":"Utting JC, et al. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res. 2006;312(10):1693\u2013702.","journal-title":"Exp Cell Res."},{"issue":"3","key":"842_CR76","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00223-004-0285-8","volume":"77","author":"A Brandao-Burch","year":"2005","unstructured":"Brandao-Burch A, et al. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization. Calcif Tissue Int. 2005;77(3):167\u201374.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"842_CR77","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bone.2011.08.004","volume":"49","author":"JH Holstein","year":"2011","unstructured":"Holstein JH, et al. Erythropoietin stimulates bone formation, cell proliferation, and angiogenesis in a femoral segmental defect model in mice. Bone. 2011;49(5):1037\u201345.","journal-title":"Bone"},{"key":"842_CR78","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12015-013-9476-x","volume":"10","author":"JHD R\u00f6lfing","year":"2014","unstructured":"R\u00f6lfing JHD, et al. The osteogenic effect of erythropoietin on human mesenchymal stromal cells is dose-dependent and involves non-hematopoietic receptors and multiple intracellular signaling pathways. Stem Cell Rev Rep. 2014;10:69\u201378.","journal-title":"Stem Cell Rev Rep."},{"issue":"1","key":"842_CR79","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41413-021-00157-x","volume":"9","author":"M Rauner","year":"2021","unstructured":"Rauner M, et al. Epo\/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss. Bone Res. 2021;9(1):42.","journal-title":"Bone Res"},{"key":"842_CR80","doi-asserted-by":"crossref","unstructured":"Awida Z, et al, Erythropoietin receptor (EPOR) signaling in the osteoclast lineage contributes to EPO-induced bone loss in mice. Int J Mol Sci, 2022;23(19).","DOI":"10.3390\/ijms231912051"},{"key":"842_CR81","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.12659\/MSM.899485","volume":"22","author":"G Wang","year":"2016","unstructured":"Wang G, et al. Short-term hypoxia accelerates bone loss in ovariectomized rats by suppressing osteoblastogenesis but enhancing osteoclastogenesis. Med Sci Monit. 2016;22:2962\u201371.","journal-title":"Med Sci Monit."},{"issue":"4","key":"842_CR82","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1007\/s11033-021-06358-1","volume":"48","author":"A Rahman","year":"2021","unstructured":"Rahman A, et al. Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mole Biology Rep. 2021;48(4):3863\u20139.","journal-title":"Mole Biology Rep."},{"key":"842_CR83","doi-asserted-by":"publisher","first-page":"1062491","DOI":"10.3389\/fcvm.2023.1062491","volume":"10","author":"M Xiang","year":"2023","unstructured":"Xiang M, et al. The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury. Front Cardiovasc Med. 2023;10:1062491.","journal-title":"Front Cardiovasc Med"},{"key":"842_CR84","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","volume":"40","author":"T Ono","year":"2020","unstructured":"Ono T, et al. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen. 2020;40:2.","journal-title":"Inflamm Regen"},{"key":"842_CR85","doi-asserted-by":"crossref","unstructured":"Bemquerer, L.M., et al., Clinical, immunological, and microbiological analysis of the association between periodontitis and COVID-19: a case-control study. Odontology, 2023: 1-13.","DOI":"10.1007\/s10266-023-00811-2"},{"key":"842_CR86","doi-asserted-by":"publisher","first-page":"121750","DOI":"10.1016\/j.lfs.2023.121750","volume":"324","author":"CM Queiroz-Junior","year":"2023","unstructured":"Queiroz-Junior CM, et al. Acute coronavirus infection triggers a TNF-dependent osteoporotic phenotype in mice. Life Sci. 2023;324:121750.","journal-title":"Life Sci."},{"issue":"2","key":"842_CR87","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11914-014-0209-0","volume":"12","author":"M Brotto","year":"2014","unstructured":"Brotto M, Johnson ML. Endocrine crosstalk between muscle and bone. Curr Osteoporos Rep. 2014;12(2):135\u201341.","journal-title":"Curr Osteoporos Rep."},{"issue":"22","key":"842_CR88","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","volume":"94","author":"CG Amanda","year":"2020","unstructured":"Amanda CG, Anthony AA. COVID-19 and neuromuscular disorders. Neurology. 2020;94(22):959.","journal-title":"Neurology"},{"issue":"6","key":"842_CR89","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/jmv.25757","volume":"92","author":"L-Q Li","year":"2020","unstructured":"Li L-Q, et al. COVID-19 patients\u2019 clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virology. 2020;92(6):577\u201383.","journal-title":"J Med Virology"},{"key":"842_CR90","doi-asserted-by":"crossref","unstructured":"Garcia-Dominguez MA, et al., A single-center retrospective study of hospitalized COVID-19 patients: demographics, laboratory markers, neurological complications, ICU admission, and mortality. Annals of Medicine and Surgery, 2023;85(7).","DOI":"10.1097\/MS9.0000000000000949"},{"issue":"3","key":"842_CR91","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/bmjebm-2020-111536","volume":"26","author":"M Preeti","year":"2021","unstructured":"Preeti M, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evidence-Based Med. 2021;26(3):107.","journal-title":"BMJ Evidence-Based Med."},{"issue":"8","key":"842_CR92","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.radcr.2021.05.019","volume":"16","author":"G Hookey","year":"2021","unstructured":"Hookey G, et al. Diagnostic role of technitium-99m bone scan in severe COVID-19-associated myositis. Radiology Case Rep. 2021;16(8):2123\u20138.","journal-title":"Radiology Case Rep."},{"key":"842_CR93","doi-asserted-by":"crossref","unstructured":"HannahJR, et al, P049 Skeletal muscle involvement in COVID-19 infection: a case report and systematic review. Rheumatology, 2021;60(Supplement_1):keab247. 046.","DOI":"10.1093\/rheumatology\/keab247.046"},{"issue":"8","key":"842_CR94","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jamaneurol.2021.2004","volume":"78","author":"T Aschman","year":"2021","unstructured":"Aschman T, et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neuro. 2021;78(8):948\u201360.","journal-title":"JAMA Neuro."},{"key":"842_CR95","doi-asserted-by":"crossref","unstructured":"Bawor M, et al. Rhabdomyolysis after COVID-19 infection: a case report and review of the literature. Viruses, 2022;14(10).","DOI":"10.3390\/v14102255"},{"issue":"3","key":"842_CR96","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1159\/000527599","volume":"14","author":"VJ Ruijters","year":"2022","unstructured":"Ruijters VJ, et al. Rhabdomyolysis after COVID-19 comirnaty vaccination: a case report. Case Rep Neurol. 2022;14(3):429\u201332.","journal-title":"Case Rep Neurol."},{"issue":"7","key":"842_CR97","first-page":"e27291","volume":"14","author":"W Abdelmottaleb","year":"2022","unstructured":"Abdelmottaleb W, et al. COVID-19 myopericarditis with pericardial effusion complicated with cardiac tamponade and rhabdomyolysis. Cureus. 2022;14(7):e27291.","journal-title":"Cureus"},{"issue":"4","key":"842_CR98","first-page":"e37333","volume":"15","author":"AJ Nashwan","year":"2023","unstructured":"Nashwan AJ, et al. Rhabdomyolysis in critically Ill patients with COVID-19: a retrospective study. Cureus. 2023;15(4):e37333.","journal-title":"Cureus"},{"key":"842_CR99","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Andrade-Junior MCd, et al. Skeletal muscle wasting and function impairment in intensive care patients with severe COVID-19. Frontiers in Physiology, 2021;12. An interesting study showing that muscle wasting and strength decreased early with ICU stay in COVID-19 patients.","DOI":"10.3389\/fphys.2021.640973"},{"issue":"1","key":"842_CR100","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12871-021-01274-0","volume":"21","author":"C Medrinal","year":"2021","unstructured":"Medrinal C, et al. Muscle weakness, functional capacities and recovery for COVID-19 ICU survivors. BMC Anesthesiology. 2021;21(1):64.","journal-title":"BMC Anesthesiology"},{"key":"842_CR101","doi-asserted-by":"publisher","first-page":"801133","DOI":"10.3389\/fendo.2022.801133","volume":"13","author":"S Damanti","year":"2022","unstructured":"Damanti S, et al. Evaluation of muscle mass and stiffness with limb ultrasound in COVID-19 survivors. Front Endocrinol. 2022;13. https:\/\/doi.org\/10.3389\/fendo.2022.801133.","journal-title":"Front Endocrinol"},{"key":"842_CR102","doi-asserted-by":"crossref","unstructured":"De Lorenzo R, et al. Longitudinal changes in physical function and their impact on health outcomes in COVID-19 patients. Nutrients, 2023;15(20).","DOI":"10.3390\/nu15204474"},{"issue":"5","key":"842_CR103","doi-asserted-by":"publisher","first-page":"e1089","DOI":"10.1093\/cid\/ciaa1750","volume":"73","author":"B Van den Borst","year":"2021","unstructured":"Van den Borst B, et al. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021;73(5):e1089\u201398.","journal-title":"Clin Infect Dis."},{"issue":"8","key":"842_CR104","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1007\/s11606-022-07523-3","volume":"37","author":"SM Yoo","year":"2022","unstructured":"Yoo SM, et al. Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med. 2022;37(8):1988\u201395.","journal-title":"J Gen Intern Med."},{"issue":"4","key":"842_CR105","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre CH, et al. Attributes and predictors of long COVID. Nature Medicine. 2021;27(4):626\u201331.","journal-title":"Nature Medicine"},{"issue":"9","key":"842_CR106","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/pmrj.12684","volume":"13","author":"JE Herrera","year":"2021","unstructured":"Herrera JE, et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. Pm r. 2021;13(9):1027\u201343.","journal-title":"Pm r"},{"issue":"9328","key":"842_CR107","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","volume":"360","author":"D Brealey","year":"2002","unstructured":"Brealey D, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360(9328):219\u201323.","journal-title":"Lancet"},{"issue":"6","key":"842_CR108","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1164\/rccm.201003-0326OC","volume":"182","author":"JE Carr\u00e9","year":"2010","unstructured":"Carr\u00e9 JE, et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Ame J Respiratory Critical Care Med. 2010;182(6):745\u201351.","journal-title":"Ame J Respiratory Critical Care Med."},{"key":"842_CR109","doi-asserted-by":"crossref","unstructured":"McKenna HT, Murray AJ, Reconsidering critical illness as an uncharacterised acquired mitochondrial disorder. SAGE Publications Sage UK: London, England; 2020. 102-104.","DOI":"10.1177\/1751143719892788"},{"issue":"7","key":"842_CR110","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1164\/rccm.201512-2344OC","volume":"194","author":"C Dos Santos","year":"2016","unstructured":"Dos Santos C, et al. Mechanisms of chronic muscle wasting and dysfunction after an intensive care unit stay A pilot study. Ame J Respira Critical Care Med. 2016;194(7):821\u201330.","journal-title":"Ame J Respira Critical Care Med."},{"issue":"28","key":"842_CR111","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3748\/wjg.v27.i28.4504","volume":"27","author":"DZ Mohamed","year":"2021","unstructured":"Mohamed DZ, et al. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol. 2021;27(28):4504.","journal-title":"World J Gastroenterol."},{"key":"842_CR112","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.clnesp.2021.03.021","volume":"43","author":"NJ Wierdsma","year":"2021","unstructured":"Wierdsma NJ, et al. Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission. Clinical Nutrition ESPEN. 2021;43:369\u201376.","journal-title":"Clinical Nutrition ESPEN"},{"issue":"4","key":"842_CR113","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1016\/j.clnu.2020.10.043","volume":"40","author":"L Di Filippo","year":"2021","unstructured":"Di Filippo L, et al. COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study. Clin Nutrition. 2021;40(4):2420\u20136.","journal-title":"Clin Nutrition"},{"key":"842_CR114","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijid.2020.08.018","volume":"100","author":"JH Im","year":"2020","unstructured":"Im JH, et al. Nutritional status of patients with COVID-19. Intern J Infect Dis. 2020;100:390\u20133.","journal-title":"Intern J Infect Dis."},{"key":"842_CR115","doi-asserted-by":"crossref","unstructured":"Chen C, et al. Plasma 25 (OH) D level is associated with the nucleic acid negative conversion time of COVID-19 patients: an exploratory study. Infect Drug Resist, 2023: 937-947.","DOI":"10.2147\/IDR.S400561"},{"issue":"17","key":"842_CR116","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1111\/febs.15495","volume":"287","author":"E Merzon","year":"2020","unstructured":"Merzon E, et al. Low plasma 25 (OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. The FEBS journal. 2020;287(17):3693\u2013702.","journal-title":"The FEBS journal"},{"key":"842_CR117","doi-asserted-by":"crossref","unstructured":"Ao T, Kikuta J, Ishii M, The effects of vitamin D on immune system and inflammatory diseases. Biomolecules, 2021;11(11).","DOI":"10.3390\/biom11111624"},{"issue":"5","key":"842_CR118","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620\u20139.","journal-title":"J Clin Invest"},{"issue":"2","key":"842_CR119","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.clim.2015.08.002","volume":"161","author":"G Treiber","year":"2015","unstructured":"Treiber G, et al. Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus\u2014a randomized clinical trial. Clin Immunol. 2015;161(2):217\u201324.","journal-title":"Clin Immunol."},{"issue":"9","key":"842_CR120","doi-asserted-by":"publisher","first-page":"e0222313","DOI":"10.1371\/journal.pone.0222313","volume":"14","author":"SA Fisher","year":"2019","unstructured":"Fisher SA, et al. The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: a systematic review. PLoS One. 2019;14(9):e0222313.","journal-title":"PLoS One"},{"issue":"1","key":"842_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-9255-5-10","volume":"5","author":"CA Peterson","year":"2008","unstructured":"Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25 (OH) D concentrations in healthy women. J Inflam. 2008;5(1):1\u20139.","journal-title":"J Inflam."},{"issue":"6","key":"842_CR122","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/sji.12547","volume":"85","author":"H Alhassan Mohammed","year":"2017","unstructured":"Alhassan Mohammed H, et al. Immunoregulation of inflammatory and inhibitory cytokines by vitamin D 3 in patients with inflammatory bowel diseases. Scandinavian J Immunol. 2017;85(6):386\u201394.","journal-title":"Scandinavian J Immunol."},{"key":"842_CR123","doi-asserted-by":"crossref","unstructured":"National Heart L, B.I.P.C.T. Network, Early high-dose vitamin D3 for critically ill, vitamin D\u2013deficient patients. New England J Med. 2019;381(26): p. 2529-2540.","DOI":"10.1056\/NEJMoa1911124"},{"issue":"1","key":"842_CR124","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1210\/clinem\/dgab599","volume":"107","author":"L di Filippo","year":"2022","unstructured":"di Filippo L, et al. Vitamin D levels are associated with blood glucose and BMI in COVID-19 patients, predicting disease severity. J Clin Endocrinol Meta. 2022;107(1):e348\u201360.","journal-title":"J Clin Endocrinol Meta."},{"key":"842_CR125","unstructured":"\u2022\u2022 di Filippo L, et al. Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors. The Journal of Clinical Endocrinology & Metabolism, 2023: dgad207. This study indicated that PASC may be predicted by 25(OH) vitamin D levels, indicating a possibility of long term skeletal effects with PASC."},{"issue":"5","key":"842_CR126","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.tjnut.2023.03.001","volume":"153","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Vitamin D and SARS-CoV-2 infection: SERVE study (SARS-CoV-2 exposure and the role of vitamin D among hospital employees). J Nutri. 2023;153(5):1420\u20136.","journal-title":"J Nutri."},{"key":"842_CR127","first-page":"1","volume":"2023","author":"L Fan","year":"2019","unstructured":"Fan L, et al. Zinc and selenium status in coronavirus disease. BioMetals. 2019;2023:1\u201313.","journal-title":"BioMetals"},{"key":"842_CR128","doi-asserted-by":"publisher","first-page":"126417","DOI":"10.1016\/j.jtemb.2019.126417","volume":"57","author":"N Amin","year":"2020","unstructured":"Amin N, et al. Zinc supplements and bone health: The role of the RANKL-RANK axis as a therapeutic target. J Trace Elements Med Bio. 2020;57:126417.","journal-title":"J Trace Elements Med Bio."},{"issue":"2","key":"842_CR129","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/molecules27020392","volume":"27","author":"T Yang","year":"2022","unstructured":"Yang T, et al. The effects of selenium on bone health: from element to therapeutics. Molecules. 2022;27(2):392.","journal-title":"Molecules"},{"key":"842_CR130","doi-asserted-by":"publisher","first-page":"126956","DOI":"10.1016\/j.jtemb.2022.126956","volume":"71","author":"E Balboni","year":"2022","unstructured":"Balboni E, et al. Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies. J Trace Elements Med Bio. 2022;71:126956.","journal-title":"J Trace Elements Med Bio."},{"issue":"1","key":"842_CR131","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","volume":"24","author":"J van Paassen","year":"2020","unstructured":"van Paassen J, et al. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Critical Care. 2020;24(1):696.","journal-title":"Critical Care"},{"issue":"1","key":"842_CR132","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","volume":"61","author":"J Compston","year":"2018","unstructured":"Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018;61(1):7\u201316.","journal-title":"Endocrine"},{"issue":"1","key":"842_CR133","doi-asserted-by":"publisher","first-page":"44618","DOI":"10.1038\/srep44618","volume":"7","author":"TW Fowler","year":"2017","unstructured":"Fowler TW, et al. Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis. Scientific Rep. 2017;7(1):44618.","journal-title":"Scientific Rep."},{"key":"842_CR134","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bonr.2018.09.004","volume":"9","author":"AS Alemi","year":"2018","unstructured":"Alemi AS, et al. Glucocorticoids cause mandibular bone fragility and suppress osteocyte perilacunar-canalicular remodeling. Bone Rep. 2018;9:145\u201353.","journal-title":"Bone Rep."},{"issue":"7","key":"842_CR135","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1210\/en.2005-0717","volume":"147","author":"C Swanson","year":"2006","unstructured":"Swanson C, et al. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. Endocrinol. 2006;147(7):3613\u201322.","journal-title":"Endocrinol."},{"key":"842_CR136","doi-asserted-by":"publisher","first-page":"155438","DOI":"10.1016\/j.cyto.2021.155438","volume":"140","author":"L Quartuccio","year":"2021","unstructured":"Quartuccio L, et al. Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia. Cytokine. 2021;140:155438.","journal-title":"Cytokine"},{"issue":"2","key":"842_CR137","doi-asserted-by":"publisher","first-page":"e3377","DOI":"10.1002\/dmrr.3377","volume":"37","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, et al. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes\/Metabolism Research and Reviews. 2021;37(2):e3377.","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"3","key":"842_CR138","doi-asserted-by":"publisher","first-page":"H403","DOI":"10.1152\/ajpheart.00204.2022","volume":"323","author":"CA Narasimhulu","year":"2022","unstructured":"Narasimhulu CA, Singla DK. Mechanisms of COVID-19 pathogenesis in diabetes. Ame J Physiology-Heart Circulatory Physio. 2022;323(3):H403\u201320.","journal-title":"Ame J Physiology-Heart Circulatory Physio."},{"issue":"2","key":"842_CR139","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12020-021-02729-7","volume":"72","author":"A Mahrooz","year":"2021","unstructured":"Mahrooz A, et al. The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism. Endocrine. 2021;72(2):317\u201325.","journal-title":"Endocrine"},{"issue":"4","key":"842_CR140","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473\u201381.","journal-title":"J Clin Invest."},{"issue":"5","key":"842_CR141","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","volume":"166","author":"M Janghorbani","year":"2007","unstructured":"Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Ame J Epidemiol. 2007;166(5):495\u2013505.","journal-title":"Ame J Epidemiol."},{"key":"842_CR142","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","volume":"16","author":"C De Laet","year":"2005","unstructured":"De Laet C, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporosis Int. 2005;16:1330\u20138.","journal-title":"Osteoporosis Int."},{"key":"842_CR143","doi-asserted-by":"publisher","first-page":"155330","DOI":"10.1016\/j.metabol.2022.155330","volume":"137","author":"H Lai","year":"2022","unstructured":"Lai H, et al. Risk of incident diabetes after COVID-19 infection: a systematic review and meta-analysis. Metabolism. 2022;137:155330.","journal-title":"Metabolism"},{"issue":"10","key":"842_CR144","doi-asserted-by":"publisher","first-page":"e1003406","DOI":"10.1371\/journal.pmed.1003406","volume":"17","author":"NV Kolhe","year":"2020","unstructured":"Kolhe NV, et al. Acute kidney injury associated with COVID-19: a retrospective cohort study. PLOS Medicine. 2020;17(10):e1003406.","journal-title":"PLOS Medicine"},{"issue":"1","key":"842_CR145","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","volume":"98","author":"JS Hirsch","year":"2020","unstructured":"Hirsch JS, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney International. 2020;98(1):209\u201318.","journal-title":"Kidney International"},{"issue":"2","key":"842_CR146","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ccc.2020.11.013","volume":"37","author":"JA Neyra","year":"2021","unstructured":"Neyra JA, Chawla LS. Acute kidney disease to chronic kidney disease. Crit Care Clin. 2021;37(2):453\u201374.","journal-title":"Crit Care Clin"},{"key":"842_CR147","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Lu JY, et al. Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI. Nephrol Dial Transplant, 2023. This paper determined the prevalence of cardiovascular and kidney complications after recovery from hospitalization with SARS-CoV-2 infection and determined the potential for long term complications from disease and the need for follow-up.","DOI":"10.1093\/ndt\/gfad020"},{"issue":"3","key":"842_CR148","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11914-017-0366-z","volume":"15","author":"EMB McNerny","year":"2017","unstructured":"McNerny EMB, Nickolas TL. Bone quality in chronic kidney disease: definitions and diagnostics. Curr Osteoporos Rep. 2017;15(3):207\u201313.","journal-title":"Curr Osteoporos Rep."},{"issue":"3","key":"842_CR149","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/jbmr.2061","volume":"29","author":"WJ Wang","year":"2014","unstructured":"Wang WJ, et al. The impact of acute kidney injury with temporary dialysis on the risk of fracture. J Bone Mineral Res. 2014;29(3):676\u201384.","journal-title":"J Bone Mineral Res."},{"key":"842_CR150","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00223-020-00777-1","volume":"108","author":"JB Cannata-And\u00eda","year":"2021","unstructured":"Cannata-And\u00eda JB, et al. Chronic kidney disease\u2014mineral and bone disorders: pathogenesis and management. Calcified Tissue Int. 2021;108:410\u201322.","journal-title":"Calcified Tissue Int."},{"issue":"2","key":"842_CR151","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","volume":"314","author":"T Shimada","year":"2004","unstructured":"Shimada T, et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophysical Res Commun. 2004;314(2):409\u201314.","journal-title":"Biochem Biophysical Res Commun."},{"issue":"3","key":"842_CR152","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Mineral Res. 2004;19(3):429\u201335.","journal-title":"J Bone Mineral Res."},{"key":"842_CR153","doi-asserted-by":"crossref","unstructured":"Wein MN, Kronenberg HM, Regulation of Bone remodeling by parathyroid hormone. Cold Spring Harb Perspect Med, 2018;8(8).","DOI":"10.1101\/cshperspect.a031237"},{"key":"842_CR154","doi-asserted-by":"crossref","unstructured":"Brandenburg V, Ketteler M, Vitamin D and secondary hyperparathyroidism in chronic kidney disease: a critical appraisal of the past, present, and the future. Nutrients, 2022;14(15).","DOI":"10.3390\/nu14153009"},{"issue":"1","key":"842_CR155","doi-asserted-by":"publisher","first-page":"20365","DOI":"10.1038\/s41598-022-24560-4","volume":"12","author":"H Zhang","year":"2022","unstructured":"Zhang H, et al. Serum vitamin D levels and acute kidney injury: a systemic review and meta-analysis. Sci Rep. 2022;12(1):20365.","journal-title":"Sci Rep"},{"key":"842_CR156","doi-asserted-by":"publisher","unstructured":"Sugatan T. Systemic activation of activin A signaling causes chronic kidney disease-mineral bone disorder. Int J Mole Sci. 2018;19. https:\/\/doi.org\/10.3390\/ijms19092490.","DOI":"10.3390\/ijms19092490"},{"key":"842_CR157","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","volume":"100","author":"KA Hruska","year":"2017","unstructured":"Hruska KA, et al. The chronic kidney disease \u2014 mineral bone disorder (CKD-MBD): Advances in pathophysiology. Bone. 2017;100:80\u20136.","journal-title":"Bone"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-023-00842-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-023-00842-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-023-00842-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T20:29:08Z","timestamp":1709843348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-023-00842-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":157,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1007\/s11914-023-00842-2","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"assertion":[{"value":"15 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Kacena serves as Editor-in- Chief for Current Osteoporosis Reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}